These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 33511087)

  • 1. Modulating TSH Receptor Signaling for Therapeutic Benefit.
    Krause G; Eckstein A; Schülein R
    Eur Thyroid J; 2020 Dec; 9(Suppl 1):66-77. PubMed ID: 33511087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting TSH and IGF-1 Receptors to Treat Thyroid Eye Disease.
    Neumann S; Krieger CC; Gershengorn MC
    Eur Thyroid J; 2020 Dec; 9(Suppl 1):59-65. PubMed ID: 33511086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms in Graves Eye Disease: Apoptosis as the End Point of Insulin-Like Growth Factor 1 Receptor Inhibition.
    Morshed SA; Ma R; Latif R; Davies TF
    Thyroid; 2022 Apr; 32(4):429-439. PubMed ID: 34927457
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of insulin-like growth factor-1 (IGF-1) pathway in the pathogenesis of Graves' orbitopathy.
    Smith TJ; Hegedüs L; Douglas RS
    Best Pract Res Clin Endocrinol Metab; 2012 Jun; 26(3):291-302. PubMed ID: 22632366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse model of Graves' orbitopathy induced by the immunization with TSHR A and IGF-1R α subunit gene.
    Wu R; Li N; Wang X; Wang S; Tan J; Wang R; Zheng W
    J Endocrinol Invest; 2024 Oct; 47(10):2507-2519. PubMed ID: 38662129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of TSHR- and IGF-1R-related pathogenesis and treatment of Graves' orbitopathy.
    Cui X; Wang F; Liu C
    Front Immunol; 2023; 14():1062045. PubMed ID: 36742308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves' disease.
    Tsui S; Naik V; Hoa N; Hwang CJ; Afifiyan NF; Sinha Hikim A; Gianoukakis AG; Douglas RS; Smith TJ
    J Immunol; 2008 Sep; 181(6):4397-405. PubMed ID: 18768899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TSH/IGF-1 Receptor Cross Talk in Graves' Ophthalmopathy Pathogenesis.
    Krieger CC; Place RF; Bevilacqua C; Marcus-Samuels B; Abel BS; Skarulis MC; Kahaly GJ; Neumann S; Gershengorn MC
    J Clin Endocrinol Metab; 2016 Jun; 101(6):2340-7. PubMed ID: 27043163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmunity in Graves' ophthalmopathy: the result of an unfortunate marriage between TSH receptors and IGF-1 receptors?
    Wiersinga WM
    J Clin Endocrinol Metab; 2011 Aug; 96(8):2386-94. PubMed ID: 21677036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential involvement of the bone marrow in experimental Graves' disease and thyroid eye disease.
    Gulbins A; Horstmann M; Keitsch S; Soddemann M; Wilker B; Wilson GC; Zeidan R; Hammer GD; Daser A; Bechrakis NE; Görtz GE; Eckstein A
    Front Endocrinol (Lausanne); 2023; 14():1252727. PubMed ID: 37810891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence That Graves' Ophthalmopathy Immunoglobulins Do Not Directly Activate IGF-1 Receptors.
    Marcus-Samuels B; Krieger CC; Boutin A; Kahaly GJ; Neumann S; Gershengorn MC
    Thyroid; 2018 May; 28(5):650-655. PubMed ID: 29631510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum antibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves' disease and Graves' orbitopathy.
    Marinò M; Rotondo Dottore G; Ionni I; Lanzolla G; Sabini E; Ricci D; Sframeli A; Mazzi B; Menconi F; Latrofa F; Vitti P; Marcocci C; Chiovato L
    J Endocrinol Invest; 2019 Apr; 42(4):471-480. PubMed ID: 30132285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linsitinib, an IGF-1R inhibitor, attenuates disease development and progression in a model of thyroid eye disease.
    Gulbins A; Horstmann M; Daser A; Flögel U; Oeverhaus M; Bechrakis NE; Banga JP; Keitsch S; Wilker B; Krause G; Hammer GD; Spencer AG; Zeidan R; Eckstein A; Philipp S; Görtz GE
    Front Endocrinol (Lausanne); 2023; 14():1211473. PubMed ID: 37435490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A New Highly Thyrotropin Receptor-Selective Small-Molecule Antagonist with Potential for the Treatment of Graves' Orbitopathy.
    Marcinkowski P; Hoyer I; Specker E; Furkert J; Rutz C; Neuenschwander M; Sobottka S; Sun H; Nazare M; Berchner-Pfannschmidt U; von Kries JP; Eckstein A; Schülein R; Krause G
    Thyroid; 2019 Jan; 29(1):111-123. PubMed ID: 30351237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TSH-Mediated TNFα Production in Human Fibrocytes Is Inhibited by Teprotumumab, an IGF-1R Antagonist.
    Chen H; Shan SJ; Mester T; Wei YH; Douglas RS
    PLoS One; 2015; 10(6):e0130322. PubMed ID: 26087256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Forkhead Transcription Factor FOXO1 Is Regulated by Both a Stimulatory Thyrotropin Receptor Antibody and Insulin-Like Growth Factor-1 in Orbital Fibroblasts from Patients with Graves' Ophthalmopathy.
    Kumar S; Coenen M; Iyer S; Bahn RS
    Thyroid; 2015 Oct; 25(10):1145-50. PubMed ID: 26213859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bidirectional TSH and IGF-1 receptor cross talk mediates stimulation of hyaluronan secretion by Graves' disease immunoglobins.
    Krieger CC; Neumann S; Place RF; Marcus-Samuels B; Gershengorn MC
    J Clin Endocrinol Metab; 2015 Mar; 100(3):1071-7. PubMed ID: 25485727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is There Evidence for IGF1R-Stimulating Abs in Graves' Orbitopathy Pathogenesis?
    Krieger CC; Neumann S; Gershengorn MC
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32911689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenic Phenotype of Adipogenesis and Hyaluronan in Orbital Fibroblasts From Female Graves' Orbitopathy Mouse Model.
    Görtz GE; Moshkelgosha S; Jesenek C; Edelmann B; Horstmann M; Banga JP; Eckstein A; Berchner-Pfannschmidt U
    Endocrinology; 2016 Oct; 157(10):3771-3778. PubMed ID: 27552248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor-1 enhances the expression of functional TSH receptor in orbital fibroblasts from thyroid-associated ophthalmopathy.
    Paik JS; Kim SE; Kim JH; Lee JY; Yang SW; Lee SB
    Immunobiology; 2020 Mar; 225(2):151902. PubMed ID: 31899052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.